Skip to main content
. 2023 Feb 16;14:1107437. doi: 10.3389/fimmu.2023.1107437

Figure 2.

Figure 2

Radar plot of percentage change in lymphocyte subsets at T1 (3 months after initiation of elexacaftor/tezacaftor/ivacaftor, red) and T2 (6 months after initiation of elexacaftor/tezacaftor/ivacaftor, blue) compared with baseline (T0).